The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Partnering Agreement with INSOMNIS Media Limited

28 Oct 2015 07:00

RNS Number : 6403D
Phorm Corporation Limited
28 October 2015
 

28 October 2015

 

Phorm Corporation Limited

("Phorm" or the "Company")

 

Partnering Agreement with INSOMNIS Media Limited

Channel sales partnership entered into with INSOMNIS to expand its technology footprint and improve global advertising campaign performance

Phorm (AIM:PHRM), a leading advertising-technology company and first party data platform provider, is pleased to announce that, further to its interim results released on 30 September 2015, it has formally entered into a channel sales partnership with INSOMNIS Media Limited ("INSOMNIS").

 

INSOMNIS, a digital media business specialising in the delivery of behavioral targeting and performance campaign solutions for its clients, will seek to leverage Phorm's proprietary technology and machine learning algorithms to identify users through a first party approach leading to more effective targeting, personalised messaging and efficient overall campaign delivery.

 

Phorm's first party data platform technology sits above digital properties, off network supply sources and real-time bidding platforms, where it synthesises user data, develops profiles and addresses users personalised with content or advertising messages at the point where the user is engaging client's websites. Brands, publishers and programmatic sources can clearly benefit when known users are able to engage with personalised content and it is therefore more effective and efficient for both the inventory and demand sides of our clients' businesses. The Company's technology provides unparalleled insight and a holistic view into digital advertising dynamics such that agencies and advertisers can achieve optimal inventory control and return on their investment.

 

 

CEO of INSOMNIS, Mr Mike Moran, commented:

 

"Brand managers have become particularly focused on whether they are messaging to their desired user base, which is often difficult to prove in the context of online advertising. Issues like privacy and viewability are becoming increasingly important to advertisers when they choose their partner for their display targeting and retargeting activity.

"We have every confidence in Phorm's tech platform and our partnership with Phorm will enable us to present our campaign metrics to clients, knowing that we have utilised first party data to deliver the brand's specific user base most efficiently. This is precisely the area where the online advertising industry needed to evolve."

 

Phorm's CEO, Timothy Smith, added:

 

"Mike Moran, Paul Grundy and their colleagues at INSOMNIS possess a wealth of ad industry expertise and relationships. Together, we've already helped a brand and publishing client in the U.K. achieve a successful campaign, which has provided validation that our initial partnership is already yielding results. We now look forward to extending this initial track record of success to the U.S. market."

 

 

-Ends-

 

 

 

For Phorm information please contact:

Phorm Corporation Limited

Timothy Smith (Chief Executive Officer) +44 (0)20 3397 6001

 

Mirabaud Securities LLP (Broker) +44 (0)20 7321 2508

Jason Woollard 

Peter Krens

 

Strand Hanson Limited (Nominated Adviser) +44 (0)20 7409 3494

James Harris Matthew Chandler James Dance

 

About Phorm

 

Phorm (PHRM:AIM) is a leading advertising-technology and first party data platform provider that enables brands and publishers to address online users with personalised content and advertising. Phorm's innovative platform delivers a more interesting online experience for the user and addressable campaign results for marketers. For more information, please visit: www.phorm.com

 

For Insomnis Media information please contact:

 

BrandMee

Marie Ellis +44 (0)7454 222611

 

About Insomnis Media

 

INSOMNIS is a digital media business specialising in behavioural targeting and driving campaign performance.

 

We use market-leading technology, which learns about our advertiser's audience, both prior to and during a campaign, which allows us to continuously improve performance by modifying CPCs/CPMs to maximise efficiency and programmatic/RTB win rates.

 

Visit us at www.insomnis-media.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRALDLLLEBFXFBQ
Date   Source Headline
19th Jun 20127:00 amRNSAGM Statement
1st Jun 20127:00 amRNSIntention to Re-Domicile
1st Jun 20127:00 amRNS£20m equity fundraising into Phorm China
22nd May 20127:00 amRNSPhorm Announces AGM Notice & Proposed Board Change
21st Mar 20127:00 amRNSAppointment of Nominated Adviser and Joint Broker
5th Mar 20127:00 amRNSTransfer of Shares
1st Mar 20127:00 amRNSTransfer of Shares
28th Dec 20117:00 amRNSDirector Dealing
12th Dec 201110:10 amRNSTransfer of Shares
7th Dec 201110:19 amRNSTransfer of Shares
2nd Dec 20112:02 pmRNSTR-1: Notification of Major Interest in Shares
2nd Dec 201112:16 pmRNSTransfer of Shares
11th Nov 20117:30 amRNSIssue of Equity
4th Nov 20117:30 amRNSIssue of Equity
21st Oct 20113:28 pmRNSIssue of Equity
20th Oct 20114:14 pmRNSTransfer of Shares
7th Oct 20112:00 pmRNSBlock Admission Return
30th Sep 20117:00 amRNSInterim Results for Six Months Ended 30 June 2011
28th Sep 20117:00 amRNSProduct Launch
30th Jun 20117:00 amRNSAnnual Financial Report
8th Apr 201112:00 pmRNSBlock Admission Return
30th Mar 20117:00 amRNSTR-1: Notification of Major Interest in Shares
22nd Mar 20117:00 amRNSPlacing and operating update
2nd Mar 201112:00 pmRNSTransfer of Shares
1st Feb 201110:14 amRNSResult of AGM
6th Jan 20117:15 amRNSOption Grant and Modification
6th Jan 20117:05 amRNSAdvisory Board Appointment - Juan Villalonga
24th Dec 20108:11 amRNSNotice of AGM
17th Dec 20109:11 amRNSIssue of convertible secured loan notes
8th Oct 20105:25 pmRNSBlock Admission Return
30th Sep 20107:00 amRNSInterim results
22nd Sep 20107:00 amRNSUpdate on Commercial Deployment in Brazil
17th Aug 20103:42 pmRNSCorrection re Share Transfer
16th Aug 20103:58 pmRNSShare Transfer
16th Aug 20108:50 amRNSDirectorate Change
30th Jul 20101:00 pmRNSTransfer of Shares
23rd Jul 201011:17 amRNSDirectorate Change
16th Jul 20104:25 pmRNSTransfer of Shares
9th Jul 20107:00 amRNSTransfer of Shares
7th Jul 20104:55 pmRNSDirector/PDMR Shareholding
7th Jul 20102:19 pmRNSPlacing of Shares
30th Jun 20102:17 pmRNSAnnual Report & Accounts Notification
30th Jun 20107:00 amRNSPreliminary Results
28th Jun 20107:00 amRNSNotification of results
8th Jun 20102:05 pmRNSChange in name of Nominated Adviser
30th Apr 20101:08 pmRNSGrant of options
9th Apr 20105:25 pmRNSBlock Admission Return
26th Mar 20107:00 amRNSCommercial Deployment in Brazil
28th Jan 20104:37 pmRNSNotification of Major Interest in Shares
11th Jan 20104:28 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.